Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Engineered Red Blood Cell-Derived Nanovesicles Functionalized with cRGD Peptide and Loaded with Acevaltrate for Targeted Ferroptosis Therapy of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) remains a highly aggressive breast cancer subtype with limited molecularly targeted treatment options, while acevaltrate (ACE), a natural dual-target ferroptosis inducer, is constrained by poor aqueous solubility and insufficient tumor accumulation. Here, we engineered cyclic Arg-...

Fu-Lan Yang, Xun Xi, Yue Yu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.